| ICD-10-CM-2023 > I00-I99 > I26-I28 > I27 |
I26-I28 | Pulmonary heart disease and diseases of pulmonary circulation | |
I27 | Other pulmonary heart diseases | |
I27.0 | Primary pulmonary hypertension | |
Info: | Heritable pulmonary arterial hypertension Idiopathic pulmonary arterial hypertension Primary group 1 pulmonary hypertension Primary pulmonary arterial hypertension | |
Excl1.: | persistent pulmonary hypertension of newborn (P29.30) pulmonary hypertension NOS (I27.20) secondary pulmonary arterial hypertension (I27.21) secondary pulmonary hypertension (I27.29) | |
I27.1 | Kyphoscoliotic heart disease | |
I27.2 | Other secondary pulmonary hypertension | |
Use add'l | associated underlying condition | |
Excl1.: | Eisenmenger's syndrome (I27.83) | |
I27.20 | Pulmonary hypertension, unspecified | |
Info: | Pulmonary hypertension NOS | |
I27.21 | Secondary pulmonary arterial hypertension | |
Info: | (Associated) (drug-induced) (toxin-induced) pulmonary arterial hypertension NOS (Associated) (drug-induced) (toxin-induced) (secondary) group 1 pulmonary hypertension | |
Use add'l | associated conditions if applicable, or adverse effects of drugs or toxins, such as: adverse effect of appetite depressants (T50.5X5) congenital heart disease (Q20-Q28) human immunodeficiency virus [HIV] disease (B20) polymyositis (M33.2-) portal hypertension (K76.6) rheumatoid arthritis (M05.-) schistosomiasis (B65.-) Sjögren syndrome (M35.0-) systemic sclerosis (M34.-) | |
I27.22 | Pulmonary hypertension due to left heart disease | |
Info: | Group 2 pulmonary hypertension | |
Use add'l | associated left heart disease, if known, such as: multiple valve disease (I08.-) rheumatic mitral valve diseases (I05.-) rheumatic aortic valve diseases (I06.-) | |
I27.23 | Pulmonary hypertension due to lung diseases and hypoxia | |
Info: | Group 3 pulmonary hypertension | |
Use add'l | associated lung disease, if known, such as: bronchiectasis (J47.-) cystic fibrosis with pulmonary manifestations (E84.0) interstitial lung disease (J84.-) pleural effusion (J90) sleep apnea (G47.3-) | |
I27.24 | Chronic thromboembolic pulmonary hypertension | |
Info: | Group 4 pulmonary hypertension | |
Use add'l | associated pulmonary embolism, if applicable (I26.-, I27.82) | |
I27.29 | Other secondary pulmonary hypertension | |
Info: | Group 5 pulmonary hypertension Pulmonary hypertension with unclear multifactorial mechanisms Pulmonary hypertension due to hematologic disorders Pulmonary hypertension due to metabolic disorders Pulmonary hypertension due to other systemic disorders | |
Use add'l | other associated disorders, if known, such as: chronic myeloid leukemia (C92.10-C92.22) essential thrombocythemia (D47.3) Gaucher disease (E75.22) hypertensive chronic kidney disease with end stage renal disease (I12.0, I13.11, I13.2) hyperthyroidism (E05.-) hypothyroidism (E00-E03) polycythemia vera (D45) sarcoidosis (D86.-) | |
I27.8 | Other specified pulmonary heart diseases | |
I27.81 | Cor pulmonale (chronic) | |
Info: | Cor pulmonale NOS | |
Excl1.: | acute cor pulmonale (I26.0-) | |
I27.82 | Chronic pulmonary embolism | |
Use add'l | code, if applicable, for associated long-term (current) use of anticoagulants (Z79.01) | |
Excl1.: | personal history of pulmonary embolism (Z86.711) | |
I27.83 | Eisenmenger's syndrome | |
Info: | Eisenmenger's complex (Irreversible) Eisenmenger's disease Pulmonary hypertension with right to left shunt related to congenital heart disease | |
Use add'l | underlying heart defect, if known, such as: atrial septal defect (Q21.1-) Eisenmenger's defect (Q21.8) patent ductus arteriosus (Q25.0) ventricular septal defect (Q21.0) | |
I27.89 | Other specified pulmonary heart diseases | |
I27.9 | Pulmonary heart disease, unspecified | |
Info: | Chronic cardiopulmonary disease | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |